---
title: "Zepbound (tirzepatide) in chronic weight management: Dosing and administration questions"
description: "Dosing and administration questions on Zepbound (tirzepatide) in chronic weight management, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing. Questions: What is the Zepbound dosing schedule? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/dosing-and-administration"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Zepbound (tirzepatide) in chronic weight management: Dosing and administration questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Zepbound](https://uspl.lilly.com/zepbound/zepbound.html#pi)

Dosing and administration questions that apply to every indication of Zepbound are on [Zepbound (tirzepatide), all indications: Dosing and administration](https://www.evicenter.com/medical-information/zepbound/dosing-and-administration).

## Dosing

<a id="zepbound-dosing-schedule"></a>

### What is the Zepbound dosing schedule?

> “The recommended starting dosage of ZEPBOUND for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks.
> The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.
> Follow the dosage escalation below for all indications to reduce the risk of gastrointestinal adverse reactions [see Warnings and Precautions (5.2) and Adverse Reactions (6.1)].
> After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly. The dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose [see Dosage and Administration (2.2)].
> Consider treatment response and tolerability when selecting the maintenance dosage. If patients do not tolerate a maintenance dosage, consider a lower maintenance dosage.”

Source: [ZEPBOUND: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/zepbound/zepbound.html#pi:~:text=The%20recommended%20starting%20dosage%20of,consider%20a%20lower%20maintenance%20dosage.)

> “Weight Reduction and Long-Term Maintenance
>
> The recommended maintenance dosage is 5 mg, 10 mg, or 15 mg, injected subcutaneously once weekly.”

Source: [ZEPBOUND: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/zepbound/zepbound.html#pi:~:text=Recommended%20Maintenance%20Dosage-,Weight%20Reduction%20and%20Long%2DTerm%20Maintenance,mg%2C%20injected%20subcutaneously%20once%20weekly.)

## Related pages
- [Medical information: Zepbound (tirzepatide): Chronic weight management](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management)
- [Indication](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/safety)
- [Access and coverage](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/access-and-coverage)
